Literature DB >> 10713444

Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.

N Adachi1, M Nomoto, K Kohno, H Koyama.   

Abstract

Expression of DNA topoisomerase (topo) IIalpha is cell-cycle-regulated, with its peak in G(2)/M and its lowest level in G(0)/G(1). In agreement with this expression pattern, we have shown that the topo IIalpha gene promoter shows cell-cycle-dependent activity, which is repressed in G(0)/G(1) and activated exclusively in G(2)/M. However, the promoter sequence reveals no canonical CDE/CHR motifs, repressor elements commonly found in promoters of late S/G(2)-activated genes. Here, we show that at least two of the three proximal inverted CCAAT boxes (ICBs) are responsible for the G(2)/M-specific activation of the topo IIalpha promoter. Using antibody supershift experiments, we identify NF-Y as the ICB-binding transcription factor. However, the expression profile and binding capacity of NF-Y were constant during the cell cycle, suggesting a more global mechanism in topo IIalpha promoter regulation. Interestingly, we find that trichostatin A (TSA), a specific histone deacetylase inhibitor, greatly enhances topo IIalpha promoter activity in an ICB-dependent manner. In addition, the effect of TSA is predominant in G(0)/G(1) and less obvious in G(2)/M. Our data, along with the recent findings that NF-Y associates in vivo with histone acetyltransferases (HATs), strongly suggest a mechanism, in which histone deacetylation plays a crucial role in the G(0)/G(1)-specific repression of the topo IIalpha promoter, and NF-Y recruits HATs to the promoter region, thereby stimulating histone acetylation and activating transcription in G(2)/M.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713444     DOI: 10.1016/s0378-1119(00)00040-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  18 in total

1.  Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.

Authors:  Natisha Magan; Agnieszka P Szremska; Richard J Isaacs; Kathryn M Stowell
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

2.  Light-mediated regulation defines a minimal promoter region of TOP2.

Authors:  G H C M Hettiarachchi; Vandana Yadav; M K Reddy; Sudip Chattopadhyay; Sudhir K Sopory
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

3.  Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells.

Authors:  J S Oh; J E Kucab; P R Bushel; K Martin; L Bennett; J Collins; R P DiAugustine; J C Barrett; C A Afshari; S E Dunn
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

Review 4.  Transcriptional modulation induced by ionizing radiation: p53 remains a central player.

Authors:  Sharon Rashi-Elkeles; Ran Elkon; Seagull Shavit; Yaniv Lerenthal; Chaim Linhart; Ana Kupershtein; Ninette Amariglio; Gideon Rechavi; Ron Shamir; Yosef Shiloh
Journal:  Mol Oncol       Date:  2011-07-07       Impact factor: 6.603

5.  Inhibition of topoisomerase IIα sensitizes FaDu cells to ionizing radiation by diminishing DNA repair.

Authors:  Ekram M Saleh
Journal:  Tumour Biol       Date:  2015-06-17

Review 6.  The regulation of DNA supercoiling across evolution.

Authors:  Alexandre Duprey; Eduardo A Groisman
Journal:  Protein Sci       Date:  2021-08-23       Impact factor: 6.993

7.  NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform.

Authors:  Eriko Toyoda; Shigehide Kagaya; Ian G Cowell; Aya Kurosawa; Keiichi Kamoshita; Kiyohiro Nishikawa; Susumu Iiizumi; Hideki Koyama; Caroline A Austin; Noritaka Adachi
Journal:  J Biol Chem       Date:  2008-07-02       Impact factor: 5.157

8.  Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.

Authors:  Chun-Nam Lok; Alexander J Lang; Shelagh E L Mirski; Susan P C Cole
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

9.  Purification of GidA protein, a novel topoisomerase II inhibitor produced by Streptomyces flavoviridis.

Authors:  Antony K Teresa Infanta S; S D Nisshanthini; M Palaniswamy; J Angayarkanni
Journal:  World J Microbiol Biotechnol       Date:  2013-08-31       Impact factor: 4.253

10.  A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response.

Authors:  Paolo Benatti; Valentina Basile; Daniele Merico; Luca Isaia Fantoni; Enrico Tagliafico; Carol Imbriano
Journal:  Nucleic Acids Res       Date:  2008-01-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.